Arena Pharmaceuticals, Inc. (ARNA)

[buzz lightyear]

Arena's Belviq Does Not Fare Well With Consumer Reports
by Spencer Osborne

Arena Pharmaceuticals (ARNA) has hit a consumer watchdog snag in the launch week of the anti-obesity drug Belviq. Consumer Reports published an article on June 13th advising consumers to seek out other alternatives. The article, titled Weight-Loss Pill Belviq Is Now Available, But We Say Skip It is pretty short and to the point. It essentially takes the track that is assigned to most weight loss products in that a preferred method to lose weight is eating properly and getting regular exercise. read more »